Endoscopic Third Ventriculostomy (ETV)
Hydrocephalus • Pediatric NeurosurgeryEndoscopic third ventriculostomy (ETV) is a minimally invasive operation for selected forms of hydrocephalus that creates an internal pathway for cerebrospinal fluid (CSF) to bypass an obstruction. Unlike a shunt, ETV does not rely on permanent implanted tubing to divert fluid to another part of the body.
Key takeaways
- ETV creates an opening in the floor of the third ventricle so cerebrospinal fluid can bypass an obstructed pathway.
- The procedure is performed with a small endoscope through a limited opening in the skull.
- ETV can allow selected children to avoid permanent shunt dependence.
- Not every type of hydrocephalus responds well to ETV; age, anatomy, and cause are important factors.
- An ETV can close and hydrocephalus can recur, including after a period of successful treatment.
- Families should remain familiar with symptoms of hydrocephalus even after a successful ETV.
| Treats | Selected forms of hydrocephalus |
| Approach | Endoscopic |
| How it works | Creates an internal CSF bypass pathway |
| Implanted shunt required | No, when ETV is successful |
| Candidacy | Based on age, cause of hydrocephalus, anatomy, and prior treatment |
| Hospital stay | Varies by age, diagnosis, and recovery |
| Long-term care | Monitoring for recurrent hydrocephalus or ETV closure |
ETV is an important alternative to shunting for selected patients, but candidacy depends on the specific CSF obstruction and the likelihood that the new pathway will remain effective.
Who May Be a Candidate for ETV?
ETV is most useful when hydrocephalus results from an obstruction that can be bypassed by creating a new CSF pathway. The neurosurgeon evaluates MRI findings, ventricular anatomy, the cause of hydrocephalus, the child’s age, and any prior shunt or CSF procedures.
ETV Versus a Shunt
A shunt moves CSF through implanted tubing to another part of the body. ETV instead creates an internal route for CSF circulation. Neither approach is universally better; the safest and most durable option depends on the child’s hydrocephalus.
How ETV Works
ETV is performed using an endoscope placed into the ventricular system through a small opening in the skull.
Entering the Ventricle
A small endoscope provides a direct view inside the ventricular system through a limited surgical corridor.
Creating the Opening
The surgeon creates a carefully positioned opening in the floor of the third ventricle.
Bypassing the Obstruction
The new opening allows CSF to flow around the blocked pathway and circulate toward normal absorption spaces.
Shunt-Free Strategy
When successful, ETV controls hydrocephalus without a permanent catheter running from the brain to the abdomen.
After ETV
After surgery, the team monitors neurological symptoms and recovery from anesthesia. Follow-up focuses on whether hydrocephalus remains controlled clinically and, when appropriate, with imaging.
Can an ETV Stop Working?
Yes. The opening can close or CSF circulation can become inadequate. Failure can occur early or after a longer period of successful treatment, so families should continue to recognize symptoms of recurrent hydrocephalus.
Benefits and risks
Potential benefits
- Creates an internal CSF pathway
- May avoid permanent shunt dependence
- No implanted distal catheter or shunt valve when successful
- Endoscopic approach through a limited surgical opening
- Can provide durable treatment in appropriately selected patients
Possible risks
- Bleeding or infection
- Injury to nearby brain or vascular structures
- Cerebrospinal fluid leak
- ETV closure or treatment failure
- Recurrent hydrocephalus requiring urgent evaluation or additional surgery
- Risks associated with general anesthesia
The likelihood of ETV success varies according to age, anatomy, cause of hydrocephalus, and prior treatment.
What recovery looks like
Recovery after ETV is individualized according to age, cause of hydrocephalus, neurological condition, and whether other procedures are performed at the same time.
- Day of surgery Neurological function and recovery from anesthesia are monitored closely.
- First few days The team watches for improvement in hydrocephalus symptoms and signs of bleeding, infection, or CSF problems.
- First 2–6 weeks Activity gradually returns to normal and follow-up assesses symptoms and healing.
- Long term Families continue to watch for recurrent hydrocephalus because an ETV can close even after a period of successful treatment.
Frequently asked questions
Is ETV the same as a shunt?
No. ETV creates an internal pathway for CSF, while a shunt uses implanted tubing to divert CSF to another part of the body.
Does ETV leave a device in the brain?
A standard ETV creates an opening for CSF flow and does not require a permanent shunt system when successful.
Can every child with hydrocephalus have ETV?
No. Candidacy depends on the cause of hydrocephalus, anatomy, age, and prior treatment.
Can ETV fail?
Yes. The opening can close or become insufficient, allowing hydrocephalus to recur.
How will I know if an ETV has stopped working?
Symptoms can include worsening headache, repeated vomiting, unusual sleepiness, irritability, vision or balance changes, seizures, developmental changes, or signs of increased pressure in an infant.
Can ETV be performed in a child who already has a shunt?
In selected cases, ETV may be considered in a child with an existing shunt. The decision depends on the original cause of hydrocephalus, current anatomy, and treatment history.
Will my child need imaging after ETV?
Follow-up is individualized and may include MRI along with clinical assessment of symptoms and neurological function.
What happens if ETV is not appropriate?
Shunt placement remains an effective treatment for many children whose hydrocephalus is not well suited to ETV.
Specialized Pediatric Hydrocephalus Care
ETV candidacy is determined by the child's anatomy, cause of hydrocephalus, age, prior treatment, and long-term CSF needs.
Second Opinions
Get another expert review of the diagnosis and treatment options.
Request a Second OpinionRelated Articles
View All Articles
When the Plan Changes: Why the Best Neurosurgeons Know When and How to Pivot
When standard treatment wasn’t possible for a patient with a complex carotid cavernous sinus fistula, Dr. Guilherme Barros changed course.…
New Hope for Brain Hemorrhages: ABS Joins Landmark Stroke Clinical Trial
Atlantic Brain and Spine is participating in the NIH-sponsored MINUTE clinical trial, studying ultra-early, minimally invasive treatment for selected patients…
Back on the Field: How Pediatric Pars Repair Helped a Teen Athlete Return to Soccer
After months of back pain threatened his soccer career, 16-year-old Nathan Young found the right diagnosis and a motion-preserving pediatric…
A Valuable Combination: How Experience and Expertise Expand Options and Improve Outcomes in Neurovascular Surgery
As neurovascular care becomes increasingly minimally invasive, Ronald P. Benitez, MD, explains why expertise in both open and endovascular surgery…
